Incomplete DPYD haplotype B3 in a patient with locally advanced gastric cancer: Reconsidering the 5-FU dosage strategy

Eur J Cancer. 2024 Jun:204:114076. doi: 10.1016/j.ejca.2024.114076. Epub 2024 Apr 20.
No abstract available

Publication types

  • Letter
  • Case Reports

MeSH terms

  • Antimetabolites, Antineoplastic / administration & dosage
  • Antimetabolites, Antineoplastic / therapeutic use
  • Dihydrouracil Dehydrogenase (NADP)* / genetics
  • Fluorouracil* / administration & dosage
  • Fluorouracil* / therapeutic use
  • Haplotypes*
  • Humans
  • Male
  • Middle Aged
  • Stomach Neoplasms* / drug therapy
  • Stomach Neoplasms* / genetics
  • Stomach Neoplasms* / pathology